Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Rockwell Medical (RMTI) Other financing activities (2020 - 2023)

Rockwell Medical filings provide 5 years of Other financing activities readings, the most recent being -$38000.0 for Q4 2023.

On a quarterly basis, Other financing activities changed N/A to -$38000.0 in Q4 2023 year-over-year; TTM through Dec 2024 was $5000.0, a 0.0% change, with the full-year FY2023 number at $5000.0, down 95.28% from a year prior.
Other financing activities hit -$38000.0 in Q4 2023 for Rockwell Medical, down from $43000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $969000.0 in Q2 2020 to a low of -$38000.0 in Q4 2023.
Median Other financing activities over the past 3 years was $43000.0 (2023), compared with a mean of $269675.6.